BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37470509)

  • 1. RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease.
    Strnad P; San Martin J
    Expert Opin Investig Drugs; 2023; 32(7):571-581. PubMed ID: 37470509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
    Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
    J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
    Wooddell CI; Blomenkamp K; Peterson RM; Subbotin VM; Schwabe C; Hamilton J; Chu Q; Christianson DR; Hegge JO; Kolbe J; Hamilton HL; Branca-Afrazi MF; Given BD; Lewis DL; Gane E; Kanner SB; Teckman JH
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32379724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fazirsiran for Liver Disease Associated with Alpha
    Strnad P; Mandorfer M; Choudhury G; Griffiths W; Trautwein C; Loomba R; Schluep T; Chang T; Yi M; Given BD; Hamilton JC; San Martin J; Teckman JH
    N Engl J Med; 2022 Aug; 387(6):514-524. PubMed ID: 35748699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
    Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
    JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleaning up alpha-1 antitrypsin deficiency related liver disease.
    Rademacher L; Fromme M; Strnad P
    Curr Opin Gastroenterol; 2023 May; 39(3):163-168. PubMed ID: 37144533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1 antitrypsin deficiency: current therapy and emerging targets.
    McElvaney OF; Fraughen DD; McElvaney OJ; Carroll TP; McElvaney NG
    Expert Rev Respir Med; 2023 Mar; 17(3):191-202. PubMed ID: 36896570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries.
    Leon C; Bouchecareilh M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
    Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
    Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.
    Guo S; Booten SL; Aghajan M; Hung G; Zhao C; Blomenkamp K; Gattis D; Watt A; Freier SM; Teckman JH; McCaleb ML; Monia BP
    J Clin Invest; 2014 Jan; 124(1):251-61. PubMed ID: 24355919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for alpha-1 antitrypsin deficiency: an update.
    Pires Ferreira D; Gruntman AM; Flotte TR
    Expert Opin Biol Ther; 2023 Mar; 23(3):283-291. PubMed ID: 36825473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding and treating COPD related to α
    Henao MP; Craig TJ
    Expert Rev Respir Med; 2016 Dec; 10(12):1281-1294. PubMed ID: 27771979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.
    Cruz PE; Mueller C; Cossette TL; Golant A; Tang Q; Beattie SG; Brantly M; Campbell-Thompson M; Blomenkamp KS; Teckman JH; Flotte TR
    Lab Invest; 2007 Sep; 87(9):893-902. PubMed ID: 17592477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Ruiz M; Lacaille F; Schrader C; Pons M; Socha P; Krag A; Sturm E; Bouchecareilh M; Strnad P
    Semin Liver Dis; 2023 Aug; 43(3):258-266. PubMed ID: 37402396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.
    Guo S; Booten SL; Watt A; Alvarado L; Freier SM; Teckman JH; McCaleb ML; Monia BP
    Rare Dis; 2014; 2():e28511. PubMed ID: 25054094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
    Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
    J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.
    Kueppers F; Andrake MD; Xu Q; Dunbrack RL; Kim J; Sanders CL
    BMC Med Genet; 2019 Jul; 20(1):125. PubMed ID: 31307431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Z Mutant Alpha-1 Antitrypsin In Vivo Using Modified DNA Antisense Oligonucleotides.
    Aghajan M; Guo S; Monia BP
    Methods Mol Biol; 2017; 1639():127-138. PubMed ID: 28752452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.
    Khodayari N; Wang RL; Oshins R; Lu Y; Millett M; Aranyos AM; Mostofizadeh S; Scindia Y; Flagg TO; Brantly M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
    Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.